Filtered By:
Specialty: Nursing
Nutrition: Sodium
This page shows you your search results in order of date.
Order by Relevance | Date
Total 378 results found since Jan 2013.
MOBILE Intervention Pilot Study in College Students With Elevated Blood Pressure
CONCLUSIONS: The results provide preliminary data on BP reduction with greater impact on the intervention group.PMID:37027130 | DOI:10.1097/JCN.0000000000000917
Source: The Journal of Cardiovascular Nursing - April 7, 2023 Category: Nursing Authors: Dieu-My T Tran Iris Martinez Chad L Cross Yumei Feng Earley Source Type: research
Initiating Continuous Renal Replacement Therapy in Patients With Transurethral Resection of Prostate Syndrome: A Case Report
J Perianesth Nurs. 2023 Jan 6:S1089-9472(22)00497-X. doi: 10.1016/j.jopan.2022.09.001. Online ahead of print.ABSTRACTWith advances and developments in hysteroscopy, cystoscopy, transurethral resection of bladder tumor, and arthroscopy, transurethral resection of prostate (TURP) syndrome has been increasingly reported. TURP syndrome is often accompanied by severe hyponatremia, fluid overload, and a plasma hypotonic state, resulting in heart failure and pulmonary and cerebral edema. Conventional treatment methods, such as intravenous infusion of hyperosmotic saline, can rapidly reverse the downward trend of serum sodium leve...
Source: Journal of Perianesthesia Nursing - January 9, 2023 Category: Nursing Authors: Dongqin Deng Qi Zhang Weifeng Tu Xinquan Yang Yinghui Qi Junlong Zhang Source Type: research
Drug Approved to Prevent Cisplatin-Associated Ototoxicity in Children
Am J Nurs. 2023 Jan 1;123(1):23. doi: 10.1097/01.NAJ.0000911520.74290.b0.ABSTRACTSodium thiosulfate injection (Pedmark) has been approved to decrease the risk of ototoxicity associated with cisplatin use in children who are at least one month old and have localized nonmetastatic solid tumors.Nurses should regularly weigh children taking this drug, as the dose is based on weight. Patients should be premedicated with antiemetics to prevent nausea and vomiting and monitored closely for evidence of electrolyte imbalances.PMID:36546383 | DOI:10.1097/01.NAJ.0000911520.74290.b0
Source: The American Journal of Nursing - December 22, 2022 Category: Nursing Authors: Diane S Aschenbrenner Source Type: research
New Drug Approved For ALS
Am J Nurs. 2023 Jan 1;123(1):22-23. doi: 10.1097/01.NAJ.0000911516.31267.67.ABSTRACTSodium phenylbutyrate-taurursodiol (Relyvrio) has been approved to treat amyotrophic lateral sclerosis.The drug was approved despite the absence of phase 3 clinical trial data. Data from a small phase 2 trial indicated that patients receiving Relyvrio had a slower loss of functioning than those taking placebo.Relyvrio poses a risk to patients who are sensitive to salt intake and to those with pancreatic, intestinal, and enterohepatic circulation disorders.PMID:36546382 | DOI:10.1097/01.NAJ.0000911516.31267.67
Source: The American Journal of Nursing - December 22, 2022 Category: Nursing Authors: Diane S Aschenbrenner Source Type: research
Drug Approved to Prevent Cisplatin-Associated Ototoxicity in Children
Am J Nurs. 2023 Jan 1;123(1):23. doi: 10.1097/01.NAJ.0000911520.74290.b0.ABSTRACTSodium thiosulfate injection (Pedmark) has been approved to decrease the risk of ototoxicity associated with cisplatin use in children who are at least one month old and have localized nonmetastatic solid tumors.Nurses should regularly weigh children taking this drug, as the dose is based on weight. Patients should be premedicated with antiemetics to prevent nausea and vomiting and monitored closely for evidence of electrolyte imbalances.PMID:36546383 | DOI:10.1097/01.NAJ.0000911520.74290.b0
Source: The American Journal of Nursing - December 22, 2022 Category: Nursing Authors: Diane S Aschenbrenner Source Type: research
New Drug Approved For ALS
Am J Nurs. 2023 Jan 1;123(1):22-23. doi: 10.1097/01.NAJ.0000911516.31267.67.ABSTRACTSodium phenylbutyrate-taurursodiol (Relyvrio) has been approved to treat amyotrophic lateral sclerosis.The drug was approved despite the absence of phase 3 clinical trial data. Data from a small phase 2 trial indicated that patients receiving Relyvrio had a slower loss of functioning than those taking placebo.Relyvrio poses a risk to patients who are sensitive to salt intake and to those with pancreatic, intestinal, and enterohepatic circulation disorders.PMID:36546382 | DOI:10.1097/01.NAJ.0000911516.31267.67
Source: The American Journal of Nursing - December 22, 2022 Category: Nursing Authors: Diane S Aschenbrenner Source Type: research
Drug Approved to Prevent Cisplatin-Associated Ototoxicity in Children
Am J Nurs. 2023 Jan 1;123(1):23. doi: 10.1097/01.NAJ.0000911520.74290.b0.ABSTRACTSodium thiosulfate injection (Pedmark) has been approved to decrease the risk of ototoxicity associated with cisplatin use in children who are at least one month old and have localized nonmetastatic solid tumors.Nurses should regularly weigh children taking this drug, as the dose is based on weight. Patients should be premedicated with antiemetics to prevent nausea and vomiting and monitored closely for evidence of electrolyte imbalances.PMID:36546383 | DOI:10.1097/01.NAJ.0000911520.74290.b0
Source: The American Journal of Nursing - December 22, 2022 Category: Nursing Authors: Diane S Aschenbrenner Source Type: research
New Drug Approved For ALS
Am J Nurs. 2023 Jan 1;123(1):22-23. doi: 10.1097/01.NAJ.0000911516.31267.67.ABSTRACTSodium phenylbutyrate-taurursodiol (Relyvrio) has been approved to treat amyotrophic lateral sclerosis.The drug was approved despite the absence of phase 3 clinical trial data. Data from a small phase 2 trial indicated that patients receiving Relyvrio had a slower loss of functioning than those taking placebo.Relyvrio poses a risk to patients who are sensitive to salt intake and to those with pancreatic, intestinal, and enterohepatic circulation disorders.PMID:36546382 | DOI:10.1097/01.NAJ.0000911516.31267.67
Source: The American Journal of Nursing - December 22, 2022 Category: Nursing Authors: Diane S Aschenbrenner Source Type: research
